Why is Ipca Labs falling/rising?

As of 29-Jul, Ipca Laboratories Ltd is experiencing a decline in its stock price, currently at 1,479.25, which reflects a decrease of 4.25 points or 0.29%. The stock has been underperforming recently, having fallen for three consecutive days with a total decline of 4.05%. It opened the day with a loss of 2.19% and reached an intraday low of Rs 1451.05. Despite positive performance over the past month with a return of 10.90%, the stock has a year-to-date decline of 12.55%. The company has shown strong fundamentals, including a low debt-to-equity ratio and positive results over the last four quarters, with a significant growth in profit after tax. However, falling investor participation, as indicated by a 52.71% drop in delivery volume compared to the five-day average, may be contributing to the current price decline.
In the broader market context, the stock's short-term performance has been relatively better than the benchmark, with a 1-week return of 1.54% compared to the Sensex's decline of 1.03%. However, the stock's year-to-date performance is notably weaker than the benchmark, which has gained 4.09%. This contrast highlights the stock's volatility and potential investor concerns despite its strong fundamentals and market-beating performance over the past year. The high institutional holdings at 46.87% suggest that knowledgeable investors are backing the stock, yet the recent price movement indicates a lack of confidence among retail investors, further exacerbated by the overall market conditions.